Arax Advisory Partners’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRT
Arax Advisory Partners's TCRT Position: Q3 2026 in Review
Arax Advisory Partners held its Alaunos Therapeutics (TCRT) position steady in Q3 2026 at 1,216 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #5010.
Arax Advisory Partners first reported a position in TCRT in Q2 2026 and has held it in 2 quarters since. The position peaked at $2.75K in Q2 2026. 24 funds tracked by Wall St. Rank hold TCRT as of Q3 2026.
- Arax Advisory Partners held 1,216 shares of Alaunos Therapeutics worth $1.08K as of Q3 2026.
- Arax Advisory Partners left its Alaunos Therapeutics share count unchanged in Q3 2026.
- Alaunos Therapeutics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #5010 holding.
- Arax Advisory Partners first reported a position in Alaunos Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Arax Advisory Partners's Alaunos Therapeutics position peaked at $2.75K in Q2 2026.
- 24 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.